Chemotherapy in advanced non-small cell lung cancer.

  title={Chemotherapy in advanced non-small cell lung cancer.},
  author={Ted A. W. Splinter},
  journal={European journal of cancer},
  volume={26 10},
Chemotherapy in advanced non-small cell lung cancer (NSCLC) has been evaluated with response rate, survival and quality of life as criteria. The data were collected from 142 phase II and III trials. The three main conclusions are: (1) multivariate landmark analyses show that a response to chemotherapy has an independent significant value for prognosis, and all studies of chemotherapy vs. best supportive care show some survival benefit in favour of chemotherapy; (2) NSCLC patients are a… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 24 extracted citations

Platinum drugs in the treatment of non-small-cell lung cancer

British Journal of Cancer • 2002
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…